ONCE DAILY CONTROLLED VERSUS IMMEDIATE RELEASE OXYBUTYNIN CHLORIDE FOR URGE URINARY INCONTINENCE
Abstract
Purpose:
We compared the efficacy and safety of once daily controlled and immediate release oxybutynin for incontinence.
Materials and Methods:
This multicenter, randomized, double-blind, active control, parallel study was designed to evaluate urge urinary incontinence episodes using a 7-day diary.
Results:
A total of 97 women and 8 men 34 to 76 years old with urge incontinence or mixed incontinence with a clinically significant urge component were enrolled in the study. The number of weekly urge incontinence episodes decreased from 27.4 to 4.8 after controlled and from 23.4 to 3.1 after immediate release oxybutynin (p = 0.56), and total incontinence episodes decreased from 29.3 to 6 and from 26.3 to 3.8, respectively (p = 0.6). Weekly urge incontinence episodes from baseline to end of study also decreased to 84% after controlled and 88% after immediate release oxybutynin (p = 0.7). Continence was achieved in 41% of the controlled and 40% of the immediate release group (p = 0.9). Dry mouth of any severity was reported by 68 and 87% of the controlled and immediate release groups, respectively (p = 0.04), and moderate or severe dry mouth occurred in 25 and 46%, respectively (p = 0.03).
Conclusions:
Participants taking a single daily does of controlled release oxybutynin had similar reductions in urge incontinence and total incontinence episodes compared to those taking oxybutynin 1 to 4 times daily. A lower incidence of dry mouth was reported for controlled release oxybutynin.
References
- 1 : Randomized double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo. J. Urol1991; 145: 813. Abstract, Google Scholar
- 2 : Conservative therapy of frequency, urgency and urge incontinence: a double-blind clinical trial of flavoxate hydrochloride, oxybutynin chloride, emepronium bromide and placebo. World J. Urol.1987; 5: 57. Google Scholar
- 3 : The use of oxybutynin in urological practice. Int. Urol. Nephrol.1987; 19: 385. Google Scholar
- 4 : Efficacy of bladder training in older women with urinary incontinence. J.A.M.A.1991; 265: 609. Google Scholar
- 5 : A comparison of effectiveness of biofeedback and pelvic muscle exercise treatment of stress incontinence in older community-dwelling women. J. Gerontol.1993; 48: M167. Google Scholar
- 6 : Randomized double-blind trial of terodiline in the treatment of urge incontinence in women. Obst. Gynec.1994; 84: 386. Google Scholar
- 7 : Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drug Aging1995; 6: 243. Google Scholar
- 8 : Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin. Submitted for publication. J. Clin. Pharm.1999; 39: 22. Google Scholar
- 9 : The urinary diary in evaluation of incontinent women: a test-retest analysis. Obst. Gynec.1988; 71: 812. Google Scholar
- 10 : Diagnosis and management of urinary incontinence due to detrusor instability. Obst. Gynec. Surv.1990; 45: 1S. Google Scholar
- 11 : Oxybutynin versus propantheline in the management of detrusor instability. A patient-regulated variable dose trail. Brit. J. Obst. Gynaec.1989; 96: 607. Google Scholar
For the OROS* Oxybutynin Study Group [dagger]; From the Department of Urology, Stanford University Medical Center, Stanford and University of California, San Francisco, California, Urology Clinic, Portland, Oregon, Rhode Island Urodynamics, Inc., Providence, Rhode Island, and Institute for Clinical Research, Inc., San Antonio and Houston, Texas
*ALZA Corporation, Palo Alto, California.
[dagger] Members: Stephen Auerbach, Newport Beach, California; C. Gilberto Brito, Phoenix, Arizona; Stanley Brosman, Santa Monica, California; Melvin Duckett, Baltimore, Maryland; Eugene Dula, Van Nuys, California; Joel Kaufman, Aurora, Colorado; Myron Murdock, Greenbelt, Maryland; and W. Lamar Weems, Jackson, Mississippi.
